Specialized Pan-antiallergy Vaccines for Niche Environments
Legal Citation
Summary of the Inventive Concept
A novel approach to adapt the pan-antiallergy vaccine for specific, high-need markets or unique operational environments, ensuring effective treatment in challenging conditions.
Background and Problem Solved
The original pan-antiallergy vaccine patent provides a groundbreaking solution for IgE-mediated allergies. However, its application in specialized contexts, such as high-altitude environments, disaster relief, tropical regions, high-security facilities, or extreme weather conditions, requires tailored adaptations to ensure optimal performance. The new inventive concept addresses these limitations by introducing specialized variations and niche solutions.
Detailed Description of the Inventive Concept
The inventive concept encompasses a range of adaptations to the original protein construct, composition, and method of making. These adaptations cater to specific operational environments, including high-altitude environments (optimized scaffold segment for low oxygen levels), disaster relief (composition with adjuvant for enhanced immune response under stress), tropical regions (motif segment modified for tropical allergens), high-security facilities (integrated detection system for IgE levels), and extreme weather conditions (pharmaceutically acceptable excipient for enhanced stability).
Novelty and Inventive Step
The new claims introduce novel and non-obvious adaptations to the original pan-antiallergy vaccine, providing a unique solution for each specialized context. These adaptations are not obvious from the original patent and require a deep understanding of the underlying technology and the specific challenges of each niche environment.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include adaptations for other specialized contexts, such as space exploration, high-latitude environments, or areas with unique allergen profiles. Variations could also involve different scaffold segments, motif segments, or adjuvants to further tailor the vaccine to specific needs.
Potential Commercial Applications and Market
The specialized pan-antiallergy vaccines for niche environments have significant commercial potential in various industries, including pharmaceuticals, biotechnology, and healthcare. Target markets include high-altitude regions, disaster relief organizations, tropical countries, high-security facilities, and industries operating in extreme weather conditions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/395 |
| A | A61 | A61K2039/544 |
| A | A61 | A61K2039/555 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Immunology, protein engineering, and vaccine development, with specific focus on IgE-mediated allergy treatments and protein construct design
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with advanced degrees in molecular biology or immunology, experienced in protein modification, computational modeling, and vaccine design, familiar with techniques for scaffold protein manipulation and epitope engineering
Obviousness Rationale
A person of ordinary skill would recognize that the disclosed variations represent predictable extensions of the source patent's core technology, applying standard protein engineering techniques to adapt the pan-antiallergy vaccine for specific environmental contexts. The modifications follow established methodological approaches in protein construct design, leveraging known strategies for optimizing vaccine performance across different operational conditions. The PTD's adaptations represent routine optimization that would be apparent to a skilled practitioner familiar with protein engineering and vaccine development principles.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,623 |
|---|---|
| Title | Pan-antiallergy vaccine |
| Assignee(s) | King Abdulaziz University |